Medical Oncology Research

mesothelioma caseThe Medical Oncology Research Unit at Canberra Hospital has been operating since 1979.

It is involved in the conduct of clinical trials in cancer patients exploring new agents and methods of treating malignancies.


The Research Unit has affiliations with national cooperative trial organisations such as the Australian and New Zealand Breast Cancer Study Group (ANZBCTG), the Australasian Gastrointestinal Trials Group (AGITG), the Australian Lung Trials Group (ALTG), the Australian Gynaecological Oncology Group (AGOG)and the Australian New Zealand Urogenital and Prostate Cancer Trials Group.

We are also part of the Greater Southern Area Health Service Clinical Trials Network along with Border Medical Oncology and the Riverina Cancer Centre supported by a grant from the Cancer Institute NSW.

Through these trials important new therapies may be accessed before they become licensed, reimbursed or widely available.

They are necessary to find out if new treatments are more effective than those currently accepted as being the best available.

All clinical trial protocols are approved and monitored by the ACT Health Human Research Ethics Committee. All trials abide with the ethical principles outlined by the Declaration of Helsinki and adhere to the ICH Harmonised Tripartite guidelines for Good Clinical Practice.

Funding for the research comes from four key sources: external granting bodies, fund raising, the pharmaceutical industry and private donations. The continued financial support of clinical trials is essential if progress is to be made in the treatment and control of cancer.


We are most grateful for the support of the Cancer Council ACT, the Monaro Committee for Cancer Research and the National Cancer Research Foundation.

Tax deductible donations and bequests would be most gratefully accepted to help support the activities of the Research Unit.

Contact us

Contact Olive Doig on (02) 6244 3856.